metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Journal Information

Most cited

29
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Mark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, ... Mazen Noureddin
Ann Hepatol. 2023;28:100762
29
Open access
28
Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis
Daniela Contreras, Alejandra González-Rocha, Patricia Clark, Simón Barquera, Edgar Denova-Gutiérrez
Ann Hepatol. 2023;28:100873
28
Open access
23
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study
Ke Su, Qiuni Shen, Jian Tong, Tao Gu, Ke Xu, Han Li, Hao Chi, Yanlin Liu, ... Yunwei Han
Ann Hepatol. 2023;28:101109
23
Full text access
18
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study
Samantha Thifani Alrutz Barcelos, Amanda Souza Silva-Sperb, Helena Abadie Moraes, Larisse Longo, Bruna Concheski de Moura, Matheus Truccolo Michalczuk, Carolina Uribe-Cruz, Carlos Thadeu Schmidt Cerski, ... Mário Reis Álvares-da-Silva
Ann Hepatol. 2023;28:100769
18
Open access
17
Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease
Dongna Zhao, Haozhe Cui, Zhiqiang Shao, Liying Cao
Ann Hepatol. 2023;28:100726
17
Full text access
17
Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network
Marina Farah, Chimaobi Anugwom, Javier Diaz Ferrer, Estefania Liza Baca, Angelo Z. Mattos, João Pedro P. Possebon, Marco Arrese, Jhon Prieto, ... Jose D. Debes
Ann Hepatol. 2023;28:100876
17
Full text access
15
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action
Alexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
15
Full text access
11
Metabolic dysfunction: The silenced connection with fatty liver disease
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez
Ann Hepatol. 2023;28:101138
11
Full text access
10
Hepatitis E virus superinfection impairs long-term outcome in hospitalized patients with hepatitis B virus-related decompensated liver cirrhosis
Hong Zhao, Wenyi Ye, Xia Yu, Jianhua Hu, Xuan Zhang, Meifang Yang, Jifang Sheng, Yu Shi
Ann Hepatol. 2023;28:100878
10
Full text access
10
Liver diseases: Perspective from the Philippines
Eric David Ornos, Karl Jeffrey Murillo, Janus P. Ong
Ann Hepatol. 2023;28:101085
10
Full text access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos